Ischemic Heart Disease (IHD) Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting ischemic heart disease (ihd) clinical trials across 4 countries. Studies span Not Applicable. Top locations include Aalborg, Denmark, Beijing, Beijing Municipality, China, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Ischemic Heart Disease (IHD) Trials at a Glance

7 actively recruiting trials for ischemic heart disease (ihd) are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Aalborg, Beijing, and Boston. Lead sponsors running ischemic heart disease (ihd) studies include Abbott Medical Devices, Brigham and Women's Hospital, and Aalborg University Hospital.

Browse ischemic heart disease (ihd) trials by phase

Treatments under study

About Ischemic Heart Disease (IHD) Clinical Trials

Looking for clinical trials for Ischemic Heart Disease (IHD)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ischemic Heart Disease (IHD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ischemic Heart Disease (IHD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Revascularization of Calcified Coronary Arteries

Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)Ischemic Heart Disease (IHD)
Aalborg University Hospital100 enrolled1 locationNCT07724184
Recruiting
Not Applicable

The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

Cardiac Magnetic Resonance ImagingIschemic Heart Disease (IHD)Myocardial Blood Flow
Brigham and Women's Hospital1,000 enrolled12 locationsNCT06854458
Recruiting

Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease

CardiomyopathyCardiovascular DiseasesHeart Valve Diseases+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University2,000 enrolled1 locationNCT07617844
Recruiting
Not Applicable

Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)

DepressionAnxietyIschemic Heart Disease (IHD)
University of Southern Denmark30 enrolled3 locationsNCT07569458
Recruiting
Not Applicable

A Clinical Evaluation of AMJ-401

Ischemic Heart Disease (IHD)
Abbott Medical Devices50 enrolled10 locationsNCT07373353
Recruiting

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

Coronary Artery DiseaseIschemic Heart Disease (IHD)Myocardial Viability
University of Texas Southwestern Medical Center30 enrolled1 locationNCT06047028
Recruiting

CMR Prognostic Markers in Ischemic Heart Disease

Myocardial Infarction (MI)Ischemic Heart Disease (IHD)
Chinese Academy of Medical Sciences, Fuwai Hospital1,000 enrolled1 locationNCT07351825